Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
about
Metabolic and cardiovascular complications in the liver transplant recipientCardiac allograft vasculopathy: current knowledge and future direction.Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements.Weight gain and cardiovascular risk after organ transplantation.New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT.Reducing adverse effects of immunosuppressive agents in kidney transplant recipients.Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.Chronic kidney disease stage progression in liver transplant recipients.Cardiovascular complications of immunosuppressive agents in renal transplant recipients.Natural history and epidemiology of post transplantation diabetes mellitus.Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus.Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.Hand transplantation: the state-of-the-art.Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+ Stores.Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up.New-onset diabetes mellitus after solid organ transplantation.Management of diabetes in patients with chronic kidney disease.Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.Glycemic control and organ transplantation.Prevention and management of transplant-associated diabetes.Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).Inhibition of DYRK1A and GSK3B induces human β-cell proliferation.Post-transplant glucose status in 61 pediatric renal transplant recipients: preliminary results of five Turkish pediatric nephrology centers.Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.Recorded delirium in a national sample of elderly inpatients: potential implications for recognition.Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy.Study of factors affecting the incidence of skin cancer in patients after liver transplant.Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.Post-transplant diabetes mellitus.Hollow polydimethylsiloxane beads with a porous structure for cell encapsulation.Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance.Medical issues in treating renal transplant patients.Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients.Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation.Care of the kidney transplant recipient. Vigilant monitoring creates the best outcome.The immunosuppressant FK506 uncovers a positive regulatory cross-talk between the Hog1p and Gcn2p pathways.Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients.Organic acids in the second morning urine in a healthy Swiss paediatric population.Diabetes mellitus after kidney transplantation: role of the impaired fasting glucose in the outcome of kidney transplantation.Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis.
P2860
Q28082243-C4A41724-A55E-4F80-B9AA-699BC7EEE3D1Q33860323-C3582F98-7DB8-4882-B7D8-DA619F7CF297Q33927283-7F15BBFE-4608-414E-B2E6-9367EF66213FQ34239244-FEF6629D-B4DE-4CA4-8025-07DD3BB0B5FEQ34368857-48AEA95A-19B7-4A98-8F6F-5A884F5A9136Q34547749-CD79D074-3059-4E02-A62C-DAE4BAC58C81Q35910576-AE475529-0753-437F-AA96-DDE2AF7BE0E6Q35985673-1EDA9EB1-BD63-4C3B-81BE-524D19BAE003Q36040739-D13650E6-C621-40FE-82DD-6A210ACBFE1EQ36295246-C24A5A59-740C-4E5D-BA11-4D2CB98FE24DQ36307547-391A4B23-FFDF-4207-94F8-7B3658C7FC39Q36394184-D17D7890-F7AF-43B8-B02A-5951929DA918Q36644873-4E77EC91-ED93-41A6-84B8-0B70EB2E7DA5Q36725795-6F8009D6-EA48-40E9-BC57-C7BBFB15F368Q36755975-11F7A537-9570-4734-9B5B-CA1B227A98BFQ37336859-8A7F8D9A-8252-489D-BBC5-E1D8817411ADQ37505862-0738C045-702B-457D-9A83-BF53978131D7Q37597058-E0EFFCB8-ED39-4E07-8C66-8A0261523892Q37689891-E66508D5-809C-4680-99C9-98979D6E5D2FQ37952000-C4FDF95E-3E63-40B1-9CAD-6351733AACB8Q38769762-8F21FB00-31E1-42F9-85F6-34B1F020B411Q38950360-466905FC-33D8-44A2-83C0-53C6DE76D4EEQ39973616-AC8C2D7E-BB1A-4AB7-8F75-CB86A0490B02Q40073566-288327D3-727B-4148-8EB7-E61D0CFFC20EQ40599830-A3BA6736-2FDE-40BE-8D5D-10A275D39ABDQ40982396-829DCC63-44FC-4741-8C81-3FF6FD473CD0Q41679985-F7569BE6-1389-4879-AABA-BE029DB6E315Q41681683-813CAAB7-0B00-41A5-9B20-6656D24DB126Q41837364-E3711898-BF75-43F7-BBD2-6A84F66AEB62Q42811772-16A097E5-BB01-475A-85AB-E8C78A04115EQ43556788-C892C371-DC2C-4C8B-8937-85FACB6AB842Q43648530-AD4B4263-3536-418A-81BE-21833D978749Q44051290-A03E1438-90FB-48D2-8157-B15AB2CF963AQ44064612-CAF7C345-F9E0-47F8-93B9-3E7EEBFC0A5DQ44165376-345DEC59-5554-4385-B6F3-649CCA5D2975Q44482169-B3D91895-9CE8-4774-9C5E-635A85DC0200Q44695735-61C23D75-0614-40FF-B5C7-51D234CF986DQ44716298-CB6B3508-93F1-49FF-A519-703047B37A5BQ45155420-68E95D3E-C56A-4CBB-96E4-BB88F15DE442Q45829609-7EACC5FF-7195-4D6E-981E-E18200C509C0
P2860
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@ast
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@en
type
label
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@ast
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@en
prefLabel
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@ast
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@en
P1476
Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.
@en
P356
10.1016/S0272-6386(99)70101-0
P577
1999-07-01T00:00:00Z